STRATA CRITICAL MEDICAL, INC. Debt Securities, Available-for-sale, Amortized Cost, Current
STRATA CRITICAL MEDICAL, INC. (SRTA) had Debt Securities, Available-for-sale, Amortized Cost, Current of $70.31 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Notes › Debt Securities, Available-for-Sale, Amortized Cost
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2022-08-09
- 2022-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $70.31M.
- 2021-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $280.26M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Current |
|---|---|
| 2022-06-30 | $70.31M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $280.26M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |